Bank of America’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Bank of America’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,118	Closed	-$5.64K	–	8089
2023 Q2	$5.64K	Sell	3,118 -44,826	-93%	-$82K	﹤0.01%	6965
2023 Q1	$63.3K	Buy	47,944 +9,240	+24%	+$15.1K	﹤0.01%	6424
2022 Q4	$65.4K	Buy	38,704 +35,582	+1,140%	+$45.1K	﹤0.01%	6398
2022 Q3	$6K	Sell	3,122 -2,553	-45%	-$7.61K	﹤0.01%	7372
2022 Q2	$17K	Sell	5,675 -11,875	-68%	-$72.5K	﹤0.01%	7233
2022 Q1	$127K	Buy	+17,550	New	+$173K	﹤0.01%	6738

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of America's PRDS Position: Q3 2023 in Review

Bank of America sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 3,118 shares — an estimated $5.64K sold.

Bank of America first reported a position in PRDS in Q1 2022 and held it in 6 quarters. The position peaked at $127K in Q1 2022. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Bank of America reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bank of America sold 3,118 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $5.64K.
Bank of America first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
Bank of America's Pardes Biosciences, Inc. Common Stock position peaked at $127K in Q1 2022.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.